The report provides a detailed analysis essential for establishing a Cefmetazole production plant. It encompasses all critical aspects necessary for Cefmetazole production, including the cost of Cefmetazole production, Cefmetazole plant cost, Cefmetazole production costs, and the overall Cefmetazole production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Cefmetazole production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Cefmetazole is a broad-spectrum antibiotic used to treat a range of bacterial infections in medical settings. It is primarily used to combat infections caused by both Gram-positive and Gram-negative bacteria, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. It is commonly given for infections of the lungs, abdomen, urinary tract, and skin, where it helps stop the growth of harmful bacteria. Moreover, Cefmetazole is often used in hospital settings for the prevention and treatment of postoperative infections, especially in abdominal and gynaecological surgeries and for patients with compromised immune systems. It is used as an alternative therapy for infections caused by bacteria resistant to other antibiotics.
The demand for Cefmetazole is mainly supported by its use as an injectable antibiotic against a wide range of pathogens for managing serious bacterial infections, which boosts its market growth. Its application as a drug for treating hospital-based infections, especially abdominal, urinary, and respiratory cases, also promotes its demand in the medical and pharmaceutical industries.
Its involvement in the treatment of certain drug-resistant infections, because of its strong activity against many gram-negative and anaerobic bacteria, further contributes to its demand in the healthcare sector. Its usage in surgical care to lower the risk of postoperative infections also adds to its demand from hospitals and clinics. Moreover, procurement choices depend on factors like the price and supply of key raw materials, compliance with production rules, and safe handling standards. Industrial Cefmetazole procurement is also shaped by production technology, supplier consistency, waste-control practices, and dependable distribution systems, which greatly influence how the product is sourced across global healthcare markets.
Raw Material for Cefmetazole Production
According to the Cefmetazole production plant project report, the major raw materials for Cefmetazole production includes 7 Beta amino 3 (1 methyl 1H tetrazole 5 S methyl) 3 cephem 4 carboxylic acid.
Production Process of Cefmetazole
The extensive Cefmetazole production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of Cefmetazole acid involves the use of 7 beta amino 3 (1 methyl 1H tetrazole 5 S methyl) 3 cephem 4 carboxylic acid as the main starting material. The carboxyl and amino groups of this compound are first protected through silanization. Then, the protected intermediate undergoes a series of chemical transformations, which include methylation, condensation, and acid hydrolysis reactions. All these steps collectively lead to the formation of Cefmetazole acid or Cefmetazole as the desired antibiotic compound.
Cefmetazole is a semisynthetic cephamycin antibiotic that appears as a white to off-white crystalline solid with no characteristic odour. The molecular formula of the compound is C15H17N7O5S3, and its molar mass is approximately 471.5 g/mol. The density of the compound is around 1.8 g/cm³. The melting point of Cefmetazole is around 163–165 degree Celsius, at which point it may begin to decompose. It is soluble in water and also shows some solubility in organic solvents like DMSO. It functions by inhibiting bacterial cell-wall synthesis via binding to penicillin-binding proteins, and because of its N-methyl-tetrazole side chain. Its prolonged use or breakdown can lead to coagulation disturbances or a disulfiram-like reaction with alcohol. The compound should be handled with care, using standard laboratory protective measures, since antibiotic powders can pose inhalation or contact risks.
